Dillione Janet bought CRMD
September 18, 2026 · Form 4 insider transaction
Dillione Janet bought 48,909 shares of CorMedix Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
48,909
Price
N/A
Total value
N/A
InsiderDillione Janet
Role—
CompanyCorMedix Inc. (CRMD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 18, 2026
Filing dateSeptember 18, 2026
Shares owned after117,835
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock.